期刊文献+

他汀类药物在缺血性脑卒中的应用

下载PDF
导出
摘要 脑卒中是严重危害中老年人的常见病,是目前导致人类死亡的三大疾病之一,且50%~70%存活者遗留有严重残疾。动脉粥样硬化是脑卒中的基本病因,其中血脂异常尤其是低密度脂蛋白胆固醇(LDL-C)的升高是缺血性脑卒中/短暂性脑缺血发作的重要危险因素之一。他汀类药物通过调脂、改善血管内皮、稳定斑块、抗栓、抗氧化、减弱炎性细胞因子反应、延缓动脉粥样硬化程度、保护神经等作用而降低脑卒中危险。
作者 胡艳格
出处 《临床合理用药杂志》 2012年第5期85-85,共1页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

参考文献1

二级参考文献22

  • 1Farnier M, Davignon J. Current and future treatment of hyperlipidemia: the role of statins. Am J Cardiol, 1998, 82: 3J - 10J.
  • 2Scandinavian Simvastatin Survival Study Gtoup.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival study(4S). Lancet, 1994, 344:1383 - 1389.
  • 3Sacks FM, Pfeffer MA, Moye LA, et al. for the cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med, 1996, 335:1001 - 1009.
  • 4The Long-Term Intervention with Pravastatin ia Ischaemic Disease(LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998, 339:1349 - 1357.
  • 5Plehn JF, Davis BR Sacks FM, et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events(CARE)study. the CARE Investigators. Circulation,1999, 99:216 -223.
  • 6Pedersen TR, Kjekshus J, Pyorala K, et al. Eeffect of simvastatin on ischemia signs and symptoms ia the Scandinavian Simvastatin Survival Study(4S). Am J Cardiol, 1998, 81:333 -335.
  • 7Shepherd J, Cobbe SM, Ford I, et al. for the West Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med,1995, 333:1301 - 1307.
  • 8Crouse JR, Byington RP, Hoen HM, et al. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med, 1997, 157:1305 -1310.
  • 9Downs JR, Clearfield M, Weis S, et al. for the AFCAPS/Tex CAPS Research Group. Primary prevention of acute coronary events with lovastatin ka men and women with average cholesterol levels. JAMA,1998, 279:1515 - 1622.
  • 10Blauw GJ, Lagaay AM, Smelt AH, et al. Stroke, statins, and cholesterol: a meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inbibitors. Stroke, 1997, 28:946 - 950.

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部